Abstract

Our primary aim was to establish the prevalence of pain within limb girdle muscular dystrophy R9 (LGMDR9). As part of the Global FKRP Registry, patients are asked to complete the Short Form McGill Pain Questionnaire (SF-MPQ) annually. We used the results of this questionnaire to determine individuals’ maximum pain score and total pain score and examined overall pain intensity and associations between pain intensity and LGMDR9 genotypes, age, and ambulatory status. We also considered the pain descriptors used and pain progression over time. Of the 502 patients, 87% reported current pain and 25% reported severe current pain. We found no associations in pain severity between the different genotypes of LGMDR9. However, we did find statistically significant associations between pain severity and ambulatory status and between our paediatric and adult populations. We found pain descriptors to be more common words that one may associate with non-neural pain, and we found that a significant number of individuals (69%) reported a fluctuating pain pattern over time. We concluded that pain should be considered a significant issue among individuals with LGMDR9 requiring management. Implications regarding assessment of pain for other degenerative diseases are discussed.

Highlights

  • IntroductionPublisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations

  • Five hundred and two patients with limb girdle muscular dystrophy R9 (LGMDR9) were reviewed from data collected from the registry’s inception in March 2011 through to May 2021

  • Our primary aim was to establish the prevalence of pain within LGMDR9 and to explore associations between the severity of pain and LGMDR9 genotype, age, and ambuOur primary aim was to We establish theto prevalence ofare pain within and to latory status

Read more

Summary

Introduction

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. Muscular dystrophies are a group of genetic neuromuscular diseases (NMD) characterised by progressive muscle weakness and wasting and dystrophic changes in skeletal muscle tissue, with loss of normal muscle fibres and their replacement by fat and connective tissue. These diseases can often have devastating effects on a person’s quality of life and in many cases on life expectancy [1]. Pain has not been regarded as a prominent symptom in most genetic

Objectives
Methods
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call